SUMMARYCD14 is a pattern-recognition receptor implicated in the in¯ammatory response to microbial components such as lipopolysaccharide, peptidoglycan and lipoarabinomannan. In this work, we made use of CD14-de®cient (CD14x/x) mice to evaluate the relative importance of CD14 in response to infection with viable, intact cells of Mycobacterium avium in vitro and in vivo. Following co-incubation of either bone marrow-derived macrophages (Mw) or thioglycollate-elicited peritoneal Mw from CD14x/x mice with viable M. avium, tumour necrosis factor (TNF) production was signi®cantly reduced and delayed compared to TNF secretion by infected CD14+/+ Mw. However, following intravenous infection with a M. avium strain of either high virulence (TMC724) or intermediate virulence (SE01), there was no difference in the bacterial loads of lungs, livers or spleens at 3, 5 and 8 weeks postinfection in CD14x/x mice when compared with syngeneic CD14+/+ mice. At these time-points, TNF and interferon-c (IFN-c) mRNA expression in the liver was similar in infected CD14+/+ and CD14x/x mice, and granuloma formation and expression of inducible nitric oxide synthase within granuloma Mw was the same in both mouse groups. In conclusion, although the absence of CD14 results in signi®cantly reduced and delayed TNF production in response to stimulation with M. avium in vitro, there is no evidence that CD14 plays a signi®cant role in either the antibacterial defence or the chronic granulomatous reaction to M. avium infection in vivo.